New report finds growing number of people in Ontario treated for opioid addiction

August 22, 2017

TORONTO, Aug. 22, 2017--The rate at which people are being prescribed opioids to treat pain in Ontario has stabilized while the amount of drugs they receive has declined considerably, a new report has found. However, nearly 40 per cent of long-acting opioids prescribed to people already using opioids to treat pain still had daily doses that exceeded new national guidelines.

The report released today by the Ontario Drug Policy Research Network said that despite these encouraging trends, opioid use patterns still varied widely across Ontario. And although opioids are being prescribed for pain similarly across all incomes, those seeking treatment for opioid addiction and those dying of an opioid-related overdose were still disproportionately from lower socio-economic groups.

"The findings of this report suggest that recent prescribing patterns may be shifting toward safer practices such as dispensing smaller quantities of opioids," said Tara Gomes, a principal investigator for the research network and a scientist at the Li Ka Shing Knowledge Institute of St. Michael's Hospital and the Institute for Clinical Evaluative Sciences. "However, we still see important differences in access to opioids to treat both pain and addiction across the province and in certain low-income populations."

Gomes said the report was the first to link data from the Narcotics Monitoring System, which was created in 2012 to capture all prescription opioids issued in Ontario, to information from other health databases to obtain detailed information about characteristics of opioid users, including income levels and other use of health-care services. For the first time they were able to look at people of all ages regardless of why they were prescribed an opioid (for pain, for addiction treatment or for cough) and regardless of how they paid for it (themselves, private insurance or the government). Most previous studies have been based on individuals eligible for the Ontario Drug Benefits Program, who are over 65 and generally have a low income and pre-existing health issues.

The report found the number of people prescribed an opioid remained relatively constant over the past five years. In 2016, 1.95 million, or one in seven Ontarians were treated with an opioid.

The total volume of opioids dispensed fell, driven by an 18 per cent reduction in opioids used to treat pain since January 2015. This reduction was primarily among long-acting opioids such as fentanyl and some forms of oxycodone, a group of drugs designed to be released slowly into the bloodstream to provide long-term pain relief. Gomes said this might be the result of new health initiatives and clinical guidelines to doctors and pharmacists on the safe use and monitoring of opioids. However, she also warned that ongoing evaluation was needed to ensure that patients are having their doses reduced safely.

The report also found that nearly 40 per cent of long-acting opioid prescriptions dispensed to people already using opioids to treat pain had daily doses that exceeded thresholds in 2017 Canadian guideline for opioid use in chronic non-cancer pain. Gomes said that this number is likely even higher because long-term opioid users are often treated with both long-acting and immediate-release opioids, which could lead even more people to exceed the guidelines' dose thresholds.

Other key findings:


Breakdown of why opioids are prescribed


The report found 11.9 per cent of Ontarians (one in eight) were prescribed an opioid for pain; 2.3 per cent (one in 43) for cough suppression and 0.4 per cent (one in 243) for opioid addiction treatment in 2016.

Disproportionate burden on the poor


Opioid use to treat pain or cough was evenly distributed across income brackets, while those receiving opioids for addiction therapy were concentrated in lower incomes. Past research by the Ontario Drug Policy Research Network has shown that opioid-related deaths are concentrated in lower incomes, suggesting that these populations may be more vulnerable to the negative consequences of opioid use.

Geographic differences


People dispensed an opioid to treat pain or addictions were concentrated in northwestern and rural regions in Ontario.

The North Bay Parry Sound and Haliburton, Kawartha, Pine Ridge Health Units had the highest per cent of residents receiving opioids for pain, 17.4 per cent of residents each.

The highest percentages of people dispensed opioids to treat addiction were in Thunder Bay District (2.2 per cent of residents), Northwestern Ontario (1.4 per cent) and Lambton, North Bay Parry Sound, and Sudbury and District, each at one per cent.

Generally, areas with the fewest people given opioids for addiction were those in which the fewest people were given opioids for pain. However, some regions with high opioid use for addiction treatment had only moderate prescribing for pain, suggesting that illicitly obtained opioids may be large contributors to opioid addiction in these areas.

Trends in addiction treatment


The number and rate of Ontarians being prescribed opioids to treat addiction are increasing, largely because of the increase in the use of the drugs buprenorphine and naloxone, especially in some northern areas. Although methadone has historically been the first line treatment for opioid use disorder in Ontario, it must be prescribed by a specially licensed physician.

Haliburton, Kawartha, Pine Ridge District, Windsor Essex County and Porcupine Health Unit had among the highest percentage of residents dispensed opioids for pain, but the percentages of residents being treated for addiction were only moderate. Moreover, those three areas had above average rates of opioid-related deaths compared with the rest of the province. These facts could suggest poor access to addiction treatment services in those areas.
-end-
About St. Michael's Hospital

St Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

The Institute for Clinical Evaluative Sciences (ICES) is an independent, non-profit organization that uses population-based health information to produce knowledge on a broad range of health care issues. Our unbiased evidence provides measures of health system performance, a clearer understanding of the shifting health care needs of Ontarians, and a stimulus for discussion of practical solutions to optimize scarce resources. ICES knowledge is highly regarded in Canada and abroad, and is widely used by government, hospitals, planners, and practitioners to make decisions about care delivery and to develop policy. For the latest ICES news, follow us on Twitter: @ICESOntario

Media contacts:

Leslie Shepherd, Manager, Media Strategy
St. Michael's Hospital
416-864-6094
shepherdl@smh.ca

Inspired Care. Inspiring Science.

http://www.stmichaelshospital.com

Follow us on Twitter: http://www.twitter.com/stmikeshospital

Deborah Creatura
Media Advisor, ICES
deborah.creatura@ices.on.ca
(o) 416-480-4780 or (c) 647-406-5996

St. Michael's Hospital

Related Pain Articles from Brightsurf:

Pain researchers get a common language to describe pain
Pain researchers around the world have agreed to classify pain in the mouth, jaw and face according to the same system.

It's not just a pain in the head -- facial pain can be a symptom of headaches too
A new study finds that up to 10% of people with headaches also have facial pain.

New opioid speeds up recovery without increasing pain sensitivity or risk of chronic pain
A new type of non-addictive opioid developed by researchers at Tulane University and the Southeast Louisiana Veterans Health Care System accelerates recovery time from pain compared to morphine without increasing pain sensitivity, according to a new study published in the Journal of Neuroinflammation.

The insular cortex processes pain and drives learning from pain
Neuroscientists at EPFL have discovered an area of the brain, the insular cortex, that processes painful experiences and thereby drives learning from aversive events.

Pain, pain go away: new tools improve students' experience of school-based vaccines
Researchers at the University of Toronto and The Hospital for Sick Children (SickKids) have teamed up with educators, public health practitioners and grade seven students in Ontario to develop and implement a new approach to delivering school-based vaccines that improves student experience.

Pain sensitization increases risk of persistent knee pain
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis (OA), according to a new study by researchers from the Université de Montréal (UdeM) School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre (CRHMR) in collaboration with researchers at Boston University School of Medicine (BUSM).

Becoming more sensitive to pain increases the risk of knee pain not going away
A new study by researchers in Montreal and Boston looks at the role that pain plays in osteoarthritis, a disease that affects over 300 million adults worldwide.

Pain disruption therapy treats source of chronic back pain
People with treatment-resistant back pain may get significant and lasting relief with dorsal root ganglion (DRG) stimulation therapy, an innovative treatment that short-circuits pain, suggests a study presented at the ANESTHESIOLOGY® 2018 annual meeting.

Sugar pills relieve pain for chronic pain patients
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology.

Peripheral nerve block provides some with long-lasting pain relief for severe facial pain
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.

Read More: Pain News and Pain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.